Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical stu... Read more
REVOLUTION Medicines
19 followers
Kymera Therapeutics
7 followers
Dyne Therapeutics
6 followers
Biocytogen
5 followers
ADMA Biologics
3 followers
Ardelyx
5 followers
Genesis Therapeutics
5 followers
Scholar Rock
1 follower
Zageno
1 follower
Applied StemCell
1 follower
TrueBinding
1 follower
Monte Rosa Therapeutics
3 followers